Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Archana Anantharaman(UCSF Helen Diller Family Comprehensive Cancer Center), Pamela L. Paris(University of California, San Francisco)
Cited by 105
Related Papers
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer
|International Journal of Cancer|2013|127
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer
|The Journal of Urology|2015|88